Praxis Precision Medicines (PRAX) Non-Current Deffered Revenue (2022 - 2024)
Praxis Precision Medicines' (PRAX) quarterly Non-Current Deffered Revenue came in at $293000.0 in Q3 2024, down 80.67% year-on-year from $1.5 million in Q4 2023, and down 50.17% quarter-over-quarter from $588000.0 in Q2 2024.
Praxis Precision Medicines (PRAX) Non-Current Deffered Revenue (2022 - 2024) Analysis & Trends
Praxis Precision Medicines' Non-Current Deffered Revenue history runs 3 years deep, the most recent figure standing at $293000.0 for Q3 2024.
- On a quarterly basis, Non-Current Deffered Revenue fell 80.67% year-over-year to $293000.0 in Q3 2024; TTM through Sep 2024 was $293000.0, a 80.67% decrease from a year earlier, with the FY2023 full-year figure at $1.2 million, down 46.79% from the prior year.
- Non-Current Deffered Revenue fell to $293000.0 in Q3 2024 per PRAX's latest filing, from $588000.0 in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $2.2 million in Q4 2022 and bottomed at $293000.0 in Q3 2024.
- The 3-year median for Non-Current Deffered Revenue is $1.3 million (2023), against an average of $1.2 million.
- Across the five-year window, Non-Current Deffered Revenue tumbled 46.79% in 2023 and tumbled 80.67% in 2024, its largest moves.
- Year by year, Non-Current Deffered Revenue stood at $2.2 million in 2022, then sank by 46.79% to $1.2 million in 2023, then slumped by 74.76% to $293000.0 in 2024.
- Per Business Quant, the three latest PRAX Non-Current Deffered Revenue figures stand at $293000.0 (Q3 2024), $588000.0 (Q2 2024), and $866000.0 (Q1 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 225.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Praxis Precision Medicines | 8.98 Bn | 8.20 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 293,000.00 |
| Jun 30, 2024 | 588,000.00 |
| Mar 31, 2024 | 866,000.00 |
| Dec 31, 2023 | 1.16 Mn |
| Sep 30, 2023 | 1.52 Mn |
| Jun 30, 2023 | 1.50 Mn |
| Mar 31, 2023 | 1.77 Mn |
| Dec 31, 2022 | 2.18 Mn |